Plasma succinylacetone is persistently raised after liver transplantation in tyrosinaemia type 1

Journal of Inherited Metabolic Disease

Volumn 36, Issue 1, 2013, Pages 15-20

  Bartlett, David C ^a,b   Preece, Mary Anne ^c   Holme, Elisabeth ^d   Lloyd, Carla ^c   Newsome, Phil N ^a,b   McKiernan, Patrick J ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NITISINONE; PORPHOBILINOGEN SYNTHASE; SUCCINYLACETONE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ARTICLE; BIOACCUMULATION; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; DISEASE MARKER; ENZYME ACTIVITY; FOLLOW UP; HEPATIC ARTERY THROMBOSIS; HUMAN; HYPERSUCCINYLACETONEMIA; INFANT; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER INJURY; LIVER NODULE; LIVER TRANSPLANTATION; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT OUTCOME; TYROSINEMIA; TYROSINEMIA TYPE 1; UPREGULATION; URINE LEVEL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYCLOHEXANONES; HEPTANOATES; HUMANS; INFANT; LIVER TRANSPLANTATION; NITROBENZOATES; PORPHOBILINOGEN SYNTHASE; RETROSPECTIVE STUDIES; TYROSINEMIAS;

EID: 84872610862     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-012-9482-1     Document Type: Article

References (26)

1. Arnon R, Kerkar Davis, Anand Yin, Gonzalez-Peralta RP (2010) Liver transplantation in children with metabolic diseases: the studies of pediatric liver transplantation experience. Pediatr Transplant 14(6):796-805, available from: PM:20557477
2. Arnon R, Annunziato R, Miloh T et al. (2011) Liver transplantation for hereditary tyrosinemia type I: analysis of the UNOS database. Pediatr Transplant 15(4):400-405, available from: PM:21504522
3. Arora-Gupta N, Davies P, McKiernan P, Kelly DA (2004) The effect of long-term calcineurin inhibitor therapy on renal function in children after liver transplantation. Pediatr Transplant 8(2):145-150, available from: PM:15049794
4. Bartlett DC, Lloyd C, Mirza D, McKiernan P, Newsome P (2010) Nitisinone treatment reduces the need for liver transplantation in children with tyrosinaemia type 1 and is associated with improved post-transplant renal tubular function. Gut 59(Suppl 2) Ref Type: Abstract
5. Collier HB (1971) A study of the determination of 5-aminolevulinate hydro-lyase (delta-aminolevulinate dehydratase) activity in hemolysates of human erythrocytes. Clin Biochem 4(4):222-232, available from: PM:5005890
6. El-Karaksy H, Rashed M, El-Sayed R et al. (2010) Clinical practice. NTBC therapy for tyrosinemia type 1: how much is enough? Eur J Pediatr 169(6):689-693, available from: PM:19882170
7. Grenier A, Lescault A, Laberge C, Gagne R, Mamer O (1982) Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia. Clin Chim Acta 123(1-2):93-99, available from: PM:7116642
8. Greter J, Jacobson CE (1987) Urinary organic acids: isolation and quantification for routine metabolic screening. Clin Chem 33(4):473-480, available from: PM:3829377
9. Grompe M, St-Louis M, Demers SI, Al-Dhalimy M, Leclerc B, Tanguay RM (1994) A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I. N Engl J Med 331(6):353-357, available from: PM:8028615
10. Herzog D, Martin S, Turpin S, Alvarez F (2006) Normal glomerular filtration rate in long-term follow-up of children after orthotopic liver transplantation. Transplantation 81(5):672-677
11. Hutchesson AC, Hall SK, Preece MA, Green A (1996) Screening for tyrosinaemia type I. Arch Dis Child Fetal Neonatal Ed 74(3):F191-F194, available from: PM:8777683
12. Laberge C, Grenier A, Valet JP, Morissette J (1990) Fumarylacetoacetase measurement as a mass-screening procedure for hereditary tyrosinemia type I. Am J Hum Genet 47(2):325-328, available from: PM:2378358
13. Laine J, Salo MK, Krogerus L, Karkkainen J, Wahlroos O, Holmberg C (1995) The nephropathy of type I tyrosinemia after liver transplantation. Pediatr Res 37(5):640-645, available from: PM:7603784
14. Lindstedt S, Holme E, Lock EA, Hjalmarson O, Strandvik B (1992) Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 340(8823):813-817, available from: PM:1383656
15. Mohan N, McKiernan P, Preece MA et al. (1999) Indications and outcome of liver transplantation in tyrosinaemia type 1. Eur J Pediatr 158(Suppl 2):S49-S54, available from: PM:10603099
16. Paradis K (1996) Tyrosinemia: the Quebec experience. Clin Invest Med 19(5):311-316, available from: PM:8889268
17. Paradis K, D'Angata ID (1997) Nephropathy of tyrosinemia and its long-term outlook. J Pediatr Gastroenterol Nutr 24(1):113-114, available from: PM:9093996
18. Paradis K, Weber A, Seidman EG et al. (1990) Liver transplantation for hereditary tyrosinemia: the Quebec experience. Am J Hum Genet 47(2):338-342, available from: PM:2378360
19. Pierik LJ, van Spronsen FJ, Bijleveld CM, van Dael CM (2005) Renal function in tyrosinaemia type I after liver transplantation: a long-term follow-up. J Inherit Metab Dis 28(6):871-876, available from: PM:16435179
20. Russo PA, Mitchell GA, Tanguay RM (2001) Tyrosinemia: a review. Pediatr Dev Pathol 4(3):212-221, available from: PM:11370259
21. Santra S, Preece MA, Hulton SA, Mckiernan PJ (2008) Renal tubular function in children with tyrosinaemia type I treated with nitisinone. J Inherit Metab Dis 31(3):399-402, available from: PM:18509744
22. Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34(3):571-590, available from: PM:3588043
23. Shoemaker LR, Strife CF, Balistreri WF, Ryckman FC (1992) Rapid improvement in the renal tubular dysfunction associated with tyrosinemia following hepatic replacement. Pediatrics 89(2):251-255, available from: PM:1734392
24. Tuchman M, Whitley CB, Ramnaraine ML, Bowers LD, Fregien KD, Krivit W (1984) Determination of urinary succinylacetone by capillary gas chromatography. J Chromatogr Sci 22(5):211-215, available from: PM:6725495
25. Tuchman M, Freese DK, Sharp HL, Ramnaraine ML, Ascher N, Bloomer JR (1987) Contribution of extrahepatic tissues to biochemical abnormalities in hereditary tyrosinemia type I: study of three patients after liver transplantation. J Pediatr 110(3):399-403, available from: PM:3546650
26. Van Thiel DH, Gartner LM, Thorp FK et al. (1986) Resolution of the clinical features of tyrosinemia following orthotopic liver transplantation for hepatoma. J Hepatol 3(1):42-48, available from: PM:3018074